Charactaristics and prognosis of autoimmune antibody-positive patients of idiopathic pulmonary arterial hypertension
M. Sakayori (Chiba, Japan), A. Sekine (Chiba, Japan), N. Tanabe (Chiba, Japan), A. Naito (Chiba, Japan), T. Jujo (Chiba, Japan), T. Sugiura (Chiba, Japan), A. Shigeta (Chiba, Japan), S. Sakao (Chiba, Japan), K. Tatsumi (Chiba, Japan)
Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Sakayori (Chiba, Japan), A. Sekine (Chiba, Japan), N. Tanabe (Chiba, Japan), A. Naito (Chiba, Japan), T. Jujo (Chiba, Japan), T. Sugiura (Chiba, Japan), A. Shigeta (Chiba, Japan), S. Sakao (Chiba, Japan), K. Tatsumi (Chiba, Japan). Charactaristics and prognosis of autoimmune antibody-positive patients of idiopathic pulmonary arterial hypertension. 3600
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: